Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/06/19
End: 06/30/23
Due: 06/30/24
Phase: N/A
Priority: Normal
Start: 01/19/19
End: 05/31/19
Due: 05/31/20
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 03/31/27
Due: 03/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion | NCT03971201 | White Plains Hospital | user2@example.com | None | 2019-09-06 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |
| Effectiveness of the Adding High Fidelity Simulation to the Bleeding Control Course in Regards to Proper Tourniquet Placement Amongst School Personnel | NCT04293211 | White Plains Hospital | user2@example.com | None | 2019-01-19 | 2019-05-31 | 2020-05-31 | - | - | 2025-07-14 |
| Pancreatic Cancer Early Detection Program | NCT02206360 | White Plains Hospital | user2@example.com | None | 2014-04-30 | 2024-06-30 | 2025-06-30 | - | - | 2025-07-14 |
| Telehealth Approach to Enhancing Glycemic Control | NCT06830135 | White Plains Hospital | user2@example.com | None | 2025-04-01 | 2027-03-31 | 2028-03-31 | - | - | 2025-07-14 |